US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist
  • 70.070
  • -2.180-3.02%
Close May 6 16:00 ET
  • 71.000
  • +0.930+1.33%
Post 20:01 ET
5.97BMarket Cap-35.04P/E (TTM)

Verona Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.06%-11.56M
-143.33%-122.2M
-177.22%-28.84M
-392.30%-62.66M
19.75%-17.1M
-135.39%-13.61M
16.10%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.19%-21.31M
Net income from continuing operations
36.73%-16.32M
-218.96%-173.42M
-139.36%-33.83M
-192.52%-42.96M
-704.30%-70.84M
-54.06%-25.79M
20.86%-54.37M
-35.22%-14.13M
6.14%-14.69M
50.43%-8.81M
Operating gains losses
-128.77%-63K
304.82%3.82M
220.23%1.45M
-245.75%-1.48M
590.27%3.63M
123.50%219K
-140.28%-1.87M
51.23%-1.21M
-73.71%1.01M
-134.63%-740K
Depreciation and amortization
12.17%295K
56.28%1.06M
24.52%259K
71.61%266K
71.97%270K
67.52%263K
6.45%677K
37.75%208K
-1.27%155K
-4.85%157K
Other non cash items
1,241.86%2.31M
4,777.48%10.83M
12,528.57%4.42M
12,406.25%6M
385.42%233K
89.01%172K
18.09%222K
29.63%35K
-11.11%48K
-9.43%48K
Change In working capital
-584.86%-35.26M
58.72%-5.74M
-12,096.77%-14.88M
-641.60%-32.14M
299.54%34.01M
-1.13%7.27M
-29.43%-13.9M
-75.40%124K
53.52%-4.33M
-138.06%-17.04M
-Change in receivables
-5,141.54%-30.66M
-2,296.92%-26.46M
-2,332.11%-25.15M
-2,846.77%-8.52M
302.79%7.79M
74.71%-585K
-127.85%-1.1M
-107.91%-1.03M
111.69%310K
139.59%1.93M
-Change in inventory
---5.53M
---8.22M
---3.91M
----
----
--0
--0
--0
----
----
-Change in prepaid assets
-74,780.00%-3.74M
-253.85%-3.96M
237.19%391K
-3.81%-2.53M
-371.51%-1.81M
-100.53%-5K
-172.69%-1.12M
-133.29%-285K
-277.18%-2.44M
119.14%667K
-Change in payables and accrued expense
152.12%17.07M
388.33%31.43M
851.86%11.32M
440.34%5.97M
145.87%7.37M
-19.57%6.77M
29.73%-10.9M
89.49%-1.51M
74.98%-1.76M
-1,557.35%-16.06M
-Change in other current assets
-1,159.45%-9.98M
-115.96%-124K
-76.69%708K
-255.33%-867K
73.15%-907K
-30.84%942K
158.64%777K
7,492.50%3.04M
80.03%-244K
-1,158.93%-3.38M
-Change in other current liabilities
-1,718.79%-2.41M
202.64%1.59M
2,095.45%1.76M
-10,472.95%-21.89M
10,623.41%21.57M
114.18%149K
-358.93%-1.55M
-110.20%-88K
-210.70%-207K
3.30%-205K
Cash from discontinued investing activities
Operating cash flow
15.06%-11.56M
-143.33%-122.2M
-177.22%-28.84M
-392.30%-62.66M
19.75%-17.1M
-135.39%-13.61M
16.10%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.19%-21.31M
Investing cash flow
Cash flow from continuing investing activities
-3,243.75%-535K
-580K
-535K
0
-29K
-16K
0
0
0
0
Net PPE purchase and sale
-3,243.75%-535K
---580K
---535K
--0
---29K
---16K
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-3,243.75%-535K
---580K
---535K
--0
---29K
---16K
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
530.90%13.46M
170.04%250.78M
292.12%94.16M
-14,864.58%-7.09M
134,441.94%166.83M
-104.55%-3.12M
-34.05%92.87M
818.59%24.01M
-99.97%48K
118.00%124K
Net issuance payments of debt
--122.5M
81.47%70.24M
-448.29%-100M
--100M
--70.24M
--0
674.16%38.71M
474.24%28.71M
--0
--0
Net common stock issuance
----
71.32%97.5M
--97.5M
--0
--0
--0
-62.01%56.91M
--0
--0
--47K
Proceeds from stock option exercised by employees
532.97%5.17M
177.48%5.41M
30,900.00%924K
7,541.67%3.67M
--0
-55.34%816K
42.06%1.95M
-100.30%-3K
-87.06%48K
--77K
Net other financing activities
-2,799.42%-114.21M
1,752.78%77.63M
--95.74M
---110.76M
--96.59M
---3.94M
69.40%-4.7M
----
----
----
Cash from discontinued financing activities
Financing cash flow
530.90%13.46M
170.04%250.78M
292.12%94.16M
-14,864.58%-7.09M
134,441.94%166.83M
-104.55%-3.12M
-34.05%92.87M
818.59%24.01M
-99.97%48K
118.00%124K
Net cash flow
Beginning cash position
47.09%399.76M
19.29%271.77M
30.57%336.04M
49.45%404.6M
-12.54%254.88M
19.29%271.77M
53.54%227.83M
11.08%257.37M
142.78%270.73M
119.50%291.42M
Current changes in cash
108.13%1.36M
200.13%128M
376.02%64.79M
-450.06%-69.74M
806.57%149.7M
-126.63%-16.75M
-47.30%42.65M
365.61%13.61M
-110.43%-12.68M
-4.70%-21.19M
Effect of exchange rate changes
310.64%297K
-100.85%-11K
-234.30%-1.07M
273.46%1.18M
-96.79%16K
-120.58%-141K
187.70%1.3M
-36.32%796K
48.84%-682K
148.97%499K
End cash Position
57.49%401.42M
47.09%399.76M
47.09%399.76M
30.57%336.04M
49.45%404.6M
-12.54%254.88M
19.29%271.77M
19.29%271.77M
11.08%257.37M
142.78%270.73M
Free cash flow
11.23%-12.1M
-144.48%-122.78M
-182.36%-29.37M
-392.30%-62.66M
19.61%-17.13M
-135.66%-13.63M
16.14%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.03%-21.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.06%-11.56M-143.33%-122.2M-177.22%-28.84M-392.30%-62.66M19.75%-17.1M-135.39%-13.61M16.10%-50.22M-34.43%-10.4M29.67%-12.73M-9.19%-21.31M
Net income from continuing operations 36.73%-16.32M-218.96%-173.42M-139.36%-33.83M-192.52%-42.96M-704.30%-70.84M-54.06%-25.79M20.86%-54.37M-35.22%-14.13M6.14%-14.69M50.43%-8.81M
Operating gains losses -128.77%-63K304.82%3.82M220.23%1.45M-245.75%-1.48M590.27%3.63M123.50%219K-140.28%-1.87M51.23%-1.21M-73.71%1.01M-134.63%-740K
Depreciation and amortization 12.17%295K56.28%1.06M24.52%259K71.61%266K71.97%270K67.52%263K6.45%677K37.75%208K-1.27%155K-4.85%157K
Other non cash items 1,241.86%2.31M4,777.48%10.83M12,528.57%4.42M12,406.25%6M385.42%233K89.01%172K18.09%222K29.63%35K-11.11%48K-9.43%48K
Change In working capital -584.86%-35.26M58.72%-5.74M-12,096.77%-14.88M-641.60%-32.14M299.54%34.01M-1.13%7.27M-29.43%-13.9M-75.40%124K53.52%-4.33M-138.06%-17.04M
-Change in receivables -5,141.54%-30.66M-2,296.92%-26.46M-2,332.11%-25.15M-2,846.77%-8.52M302.79%7.79M74.71%-585K-127.85%-1.1M-107.91%-1.03M111.69%310K139.59%1.93M
-Change in inventory ---5.53M---8.22M---3.91M----------0--0--0--------
-Change in prepaid assets -74,780.00%-3.74M-253.85%-3.96M237.19%391K-3.81%-2.53M-371.51%-1.81M-100.53%-5K-172.69%-1.12M-133.29%-285K-277.18%-2.44M119.14%667K
-Change in payables and accrued expense 152.12%17.07M388.33%31.43M851.86%11.32M440.34%5.97M145.87%7.37M-19.57%6.77M29.73%-10.9M89.49%-1.51M74.98%-1.76M-1,557.35%-16.06M
-Change in other current assets -1,159.45%-9.98M-115.96%-124K-76.69%708K-255.33%-867K73.15%-907K-30.84%942K158.64%777K7,492.50%3.04M80.03%-244K-1,158.93%-3.38M
-Change in other current liabilities -1,718.79%-2.41M202.64%1.59M2,095.45%1.76M-10,472.95%-21.89M10,623.41%21.57M114.18%149K-358.93%-1.55M-110.20%-88K-210.70%-207K3.30%-205K
Cash from discontinued investing activities
Operating cash flow 15.06%-11.56M-143.33%-122.2M-177.22%-28.84M-392.30%-62.66M19.75%-17.1M-135.39%-13.61M16.10%-50.22M-34.43%-10.4M29.67%-12.73M-9.19%-21.31M
Investing cash flow
Cash flow from continuing investing activities -3,243.75%-535K-580K-535K0-29K-16K0000
Net PPE purchase and sale -3,243.75%-535K---580K---535K--0---29K---16K--0--0--0--0
Cash from discontinued investing activities
Investing cash flow -3,243.75%-535K---580K---535K--0---29K---16K--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 530.90%13.46M170.04%250.78M292.12%94.16M-14,864.58%-7.09M134,441.94%166.83M-104.55%-3.12M-34.05%92.87M818.59%24.01M-99.97%48K118.00%124K
Net issuance payments of debt --122.5M81.47%70.24M-448.29%-100M--100M--70.24M--0674.16%38.71M474.24%28.71M--0--0
Net common stock issuance ----71.32%97.5M--97.5M--0--0--0-62.01%56.91M--0--0--47K
Proceeds from stock option exercised by employees 532.97%5.17M177.48%5.41M30,900.00%924K7,541.67%3.67M--0-55.34%816K42.06%1.95M-100.30%-3K-87.06%48K--77K
Net other financing activities -2,799.42%-114.21M1,752.78%77.63M--95.74M---110.76M--96.59M---3.94M69.40%-4.7M------------
Cash from discontinued financing activities
Financing cash flow 530.90%13.46M170.04%250.78M292.12%94.16M-14,864.58%-7.09M134,441.94%166.83M-104.55%-3.12M-34.05%92.87M818.59%24.01M-99.97%48K118.00%124K
Net cash flow
Beginning cash position 47.09%399.76M19.29%271.77M30.57%336.04M49.45%404.6M-12.54%254.88M19.29%271.77M53.54%227.83M11.08%257.37M142.78%270.73M119.50%291.42M
Current changes in cash 108.13%1.36M200.13%128M376.02%64.79M-450.06%-69.74M806.57%149.7M-126.63%-16.75M-47.30%42.65M365.61%13.61M-110.43%-12.68M-4.70%-21.19M
Effect of exchange rate changes 310.64%297K-100.85%-11K-234.30%-1.07M273.46%1.18M-96.79%16K-120.58%-141K187.70%1.3M-36.32%796K48.84%-682K148.97%499K
End cash Position 57.49%401.42M47.09%399.76M47.09%399.76M30.57%336.04M49.45%404.6M-12.54%254.88M19.29%271.77M19.29%271.77M11.08%257.37M142.78%270.73M
Free cash flow 11.23%-12.1M-144.48%-122.78M-182.36%-29.37M-392.30%-62.66M19.61%-17.13M-135.66%-13.63M16.14%-50.22M-34.43%-10.4M29.67%-12.73M-9.03%-21.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.